289 related articles for article (PubMed ID: 12030908)
1. Increased menin expression in sporadic pituitary adenomas.
Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
[TBL] [Abstract][Full Text] [Related]
3. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
[TBL] [Abstract][Full Text] [Related]
4. Increased MEN1 mRNA expression in sporadic pituitary tumours.
McCabe CJ; Gittoes NJ; Sheppard MC; Franklyn JA
Clin Endocrinol (Oxf); 1999 Jun; 50(6):727-33. PubMed ID: 10468944
[TBL] [Abstract][Full Text] [Related]
5. The MEN-1 gene is rarely down-regulated in pituitary adenomas.
Asa SL; Somers K; Ezzat S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3210-2. PubMed ID: 9745428
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors.
Wenbin C; Asai A; Teramoto A; Sanno N; Kirino T
Cancer Lett; 1999 Jul; 142(1):43-7. PubMed ID: 10424779
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the MEN1 gene in sporadic pituitary adenomas from Japanese patients.
Fukino K; Kitamura Y; Sanno N; Teramoto A; Emi M
Cancer Lett; 1999 Sep; 144(1):85-92. PubMed ID: 10503881
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.
Bhuiyan MM; Sato M; Murao K; Imachi H; Namihira H; Ishida T; Takahara J; Miyauchi A
Cancer; 2001 Sep; 92(6):1393-401. PubMed ID: 11745215
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of menin in sporadic pituitary adenomas.
Theodoropoulou M; Cavallari I; Barzon L; D'Agostino DM; Ferro T; Arzberger T; Grübler Y; Schaaf L; Losa M; Fallo F; Ciminale V; Stalla GK; Pagotto U
Endocr Relat Cancer; 2004 Jun; 11(2):333-44. PubMed ID: 15163308
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
13. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
Kameya T; Tsukada T; Yamaguchi K
Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
[TBL] [Abstract][Full Text] [Related]
15. Lack of MEN1 gene mutations in 27 sporadic insulinomas.
Cupisti K; Höppner W; Dotzenrath C; Simon D; Berndt I; Röher HD; Goretzki PE
Eur J Clin Invest; 2000 Apr; 30(4):325-9. PubMed ID: 10759881
[TBL] [Abstract][Full Text] [Related]
16. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
17. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop).
Valdés N; Pérez de Nanclares G; Alvarez V; Castaño L; Díaz-Cadórniga F; Aller J; Coto E
Clin Endocrinol (Oxf); 1999 Mar; 50(3):309-13. PubMed ID: 10435055
[TBL] [Abstract][Full Text] [Related]
19. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
20. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]